Ads
related to: pfizer stock performance 2024
Search results
Results From The WOW.Com Content Network
Pfizer reported fourth quarter and full-year 2024 earnings results Tuesday, narrowly beating Wall Street expectations and its stock remained flat after market open.Pfizer reported $63.6 billion in ...
Thank you for joining us today. 2024 was a strong year of execution and performance for Pfizer. ... Elrexfio had a strong performance in 2024 with more than $130 million in full-year revenues and ...
Pfizer reported robust fourth-quarter 2024 earnings, exceeding expectations in both revenue and adjusted earnings. ... the overall performance was strong, driven by growth in non-COVID-19 products ...
*Stock Advisor returns as of October 28, 2024 Members of our leadership team will be available for the Q&A session, including Dr. Andrew Baum, who recently joined Pfizer as EVP and chief strategy ...
The $771 million adjustment to the estimated revenue reversal of $3.5 billion last quarter reflects 1.4 million fewer treatment courses returned by the U.S. government through Feb. 29, 2024 versus ...
Pfizer beat on earnings in the first quarter of 2024, giving its stock a much-needed 7% boost Wednesday.The company reported $14.9 billion in revenue, down 19% compared to last year. That beat ...
There are signs though that the reduced-performance pain may be nearing an end. ... $2.4 billion of Pfizer's $14.9 billion in first-quarter 2024 sales. ... of the market selling Pfizer stock off ...
Pfizer disappointed Wall Street this week with lower revenue guidance for the upcoming year, giving analysts another reason to doubt the company and its stock. Shares for Pfizer were at the end of ...